Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−4.76 USD
−14.57 M USD
9.13 M USD
3.12 M
About COSCIENS Biopharma Inc.
Sector
Industry
CEO
Peter Harry Puccetti
Website
Headquarters
Toronto
Founded
1990
ISIN
CA22112H1010
FIGI
BBG000LZSYB1
COSCIENS Biopharma Inc. engages in the development and commercialization of diverse pharmaceutical and diagnostic products. It operates through the Active Ingredient and Biopharmaceutical segments. The Active Ingredient segment is involved in the development of proprietary extraction technologies. The Biopharmaceutical segment includes commercializing and developing pharmaceutical therapeutics and diagnostic tests. The company was founded on September 12, 1990 and is headquartered in Toronto, Canada.
Related stocks
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of CSCIF is 2.09 USD — it has increased by 2.02% in the past 24 hours. Watch COSCIENS Biopharma Inc stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange COSCIENS Biopharma Inc stocks are traded under the ticker CSCIF.
CSCIF stock has fallen by −6.63% compared to the previous week, the month change is a −18.49% fall, over the last year COSCIENS Biopharma Inc has showed a −25.83% decrease.
CSCIF reached its all-time high on Nov 24, 2015 with the price of 15.70 USD, and its all-time low was 0.04 USD and was reached on Oct 29, 2015. View more price dynamics on CSCIF chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
CSCIF stock is 1.98% volatile and has beta coefficient of 0.81. Track COSCIENS Biopharma Inc stock price on the chart and check out the list of the most volatile stocks — is COSCIENS Biopharma Inc there?
Today COSCIENS Biopharma Inc has the market capitalization of 6.77 M, it has decreased by −6.38% over the last week.
Yes, you can track COSCIENS Biopharma Inc financials in yearly and quarterly reports right on TradingView.
COSCIENS Biopharma Inc is going to release the next earnings report on Apr 15, 2026. Keep track of upcoming events with our Earnings Calendar.
CSCIF net income for the last quarter is −1.80 M USD, while the quarter before that showed −2.75 M USD of net income which accounts for 34.48% change. Track more COSCIENS Biopharma Inc financial stats to get the full picture.
No, CSCIF doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 24, 2025, the company has 40 employees. See our rating of the largest employees — is COSCIENS Biopharma Inc on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. COSCIENS Biopharma Inc EBITDA is −10.45 M USD, and current EBITDA margin is −129.51%. See more stats in COSCIENS Biopharma Inc financial statements.
Like other stocks, CSCIF shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade COSCIENS Biopharma Inc stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So COSCIENS Biopharma Inc technincal analysis shows the sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating COSCIENS Biopharma Inc stock shows the sell signal. See more of COSCIENS Biopharma Inc technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.